Patent · US Active

Multiple kinase pathway inhibitors

US9714247B2 · kind B2 · utility

6Cited by

4References

10Claims

0Family size

Assignees

TOLERO PHARMACEUTICALS, INC. · US
MannKind Corporation · US

Inventors

Qingping Zeng · Thousand Oaks, US
Mary Faris · Los Angeles, US
Alexis Henri Abel Mollard · Salt Lake City, US
Steven L. Warner · Sandy, US
Gary A. Flynn · Cincinnati, US

Key dates

Filing date	Sep 26, 2016
Grant date	Jul 25, 2017
Priority date	—
Expiry date	Sep 26, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Kinase with inhibitory activity against kinases disposed in multiple signaling pathways and their therapeutic uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.